Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4190.50 +2.0% SILVER 57.56 +3.0% COPPER 6.56 −1.4% OIL 97.66 +2.7% PALLADIUM 1135.75 +3.6% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% NSU 0.170 +9.7% WM 0.085 +0.0% YGT 0.180 +5.9% EVI 0.500 +0.0% ADZ 0.125 +0.0% MINK 0.075 +0.0% DNO 0.300 +0.0% GOLD 4190.50 +2.0% SILVER 57.56 +3.0% COPPER 6.56 −1.4% OIL 97.66 +2.7% PALLADIUM 1135.75 +3.6% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% NSU 0.170 +9.7% WM 0.085 +0.0% YGT 0.180 +5.9% EVI 0.500 +0.0% ADZ 0.125 +0.0% MINK 0.075 +0.0% DNO 0.300 +0.0%

Technology

Page 31
  1. May 25, 2026 · 04:24 · INIK · Routine −

    Ionik Staves Off Default With Another 30-Day Debt Extension, but Underlying Distress Intensifies as Cash Runs Thin

    Ionik extends debt facility by 30 days until June 25

    01
  2. May 22, 2026 · 22:01 · INIK · Material −

    Ionik secures a 30-day lifeline as refinancing clock ticks, debt overhang darkens record earnings

    Ionik Announces 30-Day Extension of Senior Debt Facility

    02
  3. May 22, 2026 · 21:00 · BATX · Routine +

    Battery X Metals Secures $2M Financing Amidst BYD Range Validation; Stock Slides on Dilution Concerns

    Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World's Largest

    03
  4. May 22, 2026 · 20:25 · BATX · Routine +

    Battery X Metals Secures Liquidity Amidst Dilution Concerns as IPO Timeline Remains Uncertain

    Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet

    04
  5. May 22, 2026 · 18:08 · VTI · Neutral

    Valdor Technology International Inc.

    Valdor Technology rollback to take effective May 27

    05
  6. May 22, 2026 · 18:00 · AIRX · Routine +

    Redwood AI Partners with Clinical Biopharma to Validate Drug Discovery Platform Amidst Recent Price Consolidation

    Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development

    06
  7. May 22, 2026 · 11:25 · CLSZ · Neutral

    Short CLSK ETF Liquidates Amid Stock’s 78% Plunge; a technical covering bid may flicker, but no fundamental rescue in sight.

    Tradr Announces Liquidation of CLSZ, HLXX, MSQ & SRPU

    07
  8. May 22, 2026 · 08:01 · FTRC · Routine +

    FUTR Secures Liquidity Amidst Losses as Dealer Network Expands

    The FUTR Corporation to Close Fully Committed $4.75 Million Private Placement

    08
  9. May 22, 2026 · 08:01 · QSE · Routine +

    QSE Confirms Commercial Deployment Status Amidst Market Correction and Revenue Ambiguity

    Quantum Secure Encryption Highlights Post-Quantum Cybersecurity Urgency Following U.S. Quantum Computing Investment

    09
  10. May 22, 2026 · 08:00 · DM · Routine +

    Datametrex AI Limited Operational Expansion Masks Revenue Recognition Lag and Dilution Concerns

    Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership

    10
  11. May 22, 2026 · 08:00 · EQ · Routine +

    EQ Inc. Validates Growth Trajectory with Cash Flow Positive Q1, Yet Debt Maturity Looms Near Conversion Parity

    EQ Inc. Reports First Quarter 2026 Financial Results and Annual General Meeting Results

    11
  12. May 21, 2026 · 18:48 · WHIP · Routine −

    Credissential Inc.

    Credissential Announces Private Placement

    12
  13. May 21, 2026 · 17:30 · VTI · Routine −

    Valdor Technology International Consolidates Shares Amidst Penny Stock Distress

    Valdor Announces Consolidation Of Common Shares

    13
  14. May 21, 2026 · 17:24 · ICS · Routine −

    Regulatory Refiling Casts Shadow Over VEIL Commercialization Momentum

    Integrated Quantum Technologies Announces Refiling of MD&A

    14
← Newer Older →